Add BrightSurf on Google Email

Science News for April 30, 2017


Ivabradine may not benefit certain heart failure patients

A randomized clinical trial found that ivabradine did not improve outcomes in patients with heart failure with preserved ejection fraction. Elevated heart rate is a predictive factor of worse outcomes in these patients, contradicting previous research that suggested benefits for heart failure with reduced ejection fraction.

SourceWiley·JournalEuropean Journal of Heart Failure·DateApr 30, 2017